TY - JOUR
T1 - Maternal Cardiovascular Outcomes of Pregnancy in Childhood, Adolescent, and Young Adult Cancer Survivors
AU - Bansal, Neha
AU - Hazim, Carol Fernandez
AU - Badillo, Sergio
AU - Shyam, Sharvari
AU - Wolfe, Diana
AU - Bortnick, Anna E.
AU - Garcia, Mario J.
AU - Rodriguez, Carols J.
AU - Zhang, Lili
N1 - Funding Information:
L.Z. is supported by the Glorney-Raisbeck Junior Faculty Research Award In Cardiovascular Diseases from the New York Academy of Medicine. A.E.B. is supported by a K23 HL146982 from the National Heart, Lung and Blood Institute (NHLBI).
Publisher Copyright:
© 2022 by the authors.
PY - 2022/11
Y1 - 2022/11
N2 - This review focuses on the maternal cardiovascular risk and outcomes of pregnancy in childhood, adolescent, and young adult cancer survivors who are achieving survival to their prime reproductive years. Childhood, adolescent, and young adult cancer survivors are a growing population and have increasing needs for reproductive care over decades of life. Female cancer survivors have an overall higher risk of maternal cardiovascular events compared to those without a history of cancer. In female cancer survivors with normal cardiac function before pregnancy, the incidence of new heart failure during pregnancy is low. In survivors with cardiotoxicity prior to pregnancy, the risk of heart failure during and immediately after pregnancy is much higher. We recommend cardiomyopathy surveillance with echocardiography before pregnancy for all female survivors treated with anthracyclines and chest radiation. Survivors with cardiotoxicity prior to pregnancy should be cared for by an expert multidisciplinary team, including obstetrics, cardiology, anesthesia, and specialized nursing, among others.
AB - This review focuses on the maternal cardiovascular risk and outcomes of pregnancy in childhood, adolescent, and young adult cancer survivors who are achieving survival to their prime reproductive years. Childhood, adolescent, and young adult cancer survivors are a growing population and have increasing needs for reproductive care over decades of life. Female cancer survivors have an overall higher risk of maternal cardiovascular events compared to those without a history of cancer. In female cancer survivors with normal cardiac function before pregnancy, the incidence of new heart failure during pregnancy is low. In survivors with cardiotoxicity prior to pregnancy, the risk of heart failure during and immediately after pregnancy is much higher. We recommend cardiomyopathy surveillance with echocardiography before pregnancy for all female survivors treated with anthracyclines and chest radiation. Survivors with cardiotoxicity prior to pregnancy should be cared for by an expert multidisciplinary team, including obstetrics, cardiology, anesthesia, and specialized nursing, among others.
KW - cancer survivors
KW - cardiotoxicity cardiovascular outcomes
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85149556065&partnerID=8YFLogxK
U2 - 10.3390/jcdd9110373
DO - 10.3390/jcdd9110373
M3 - Review article
AN - SCOPUS:85149556065
SN - 2308-3425
VL - 9
JO - Journal of Cardiovascular Development and Disease
JF - Journal of Cardiovascular Development and Disease
IS - 11
M1 - 373
ER -